If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
4
Followers on Owler
Spherix
provides intelligence and market research services for businesses...
Read more
Overview
Acquisitions
Funding
News & Insights
Spherix
provides intelligence and market research services for businesses...
Read more
CEO
Dan Barton
CEO Approval Rating
- -/100
Weigh In
2015
Exton
Pennsylvania
Delaware Valley
Private
Pharmaceuticals & Biotechnology
Life Sciences
2836
NAICS listing
http://www.spherixglobalinsights.com/
Est. Annual Revenue
<$1M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Acquisitions
1
News
Latest News
Apr 10, 2025
StreetInsider
Press Release: Spherix : Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
Mar 27, 2025
GlobalNewswire
Press Release: Spherix : Spherix Global Insights' Tucker Hurtado Recognized as Luminary by Healthcare Businesswomen's Association
Feb 19, 2025
GlobalNewswire
Press Release: Spherix : Spherix Global Insights and the American Kidney Fund Announce Strategic Partnership and Inaugural Initiative to Elevate the Voice of Kidney Patients - Beginning with IgAN Patients
Feb 13, 2025
GlobalNewswire
Press Release: Spherix : Early Launch Metrics Indicate UCB's Bimzelx (bimekizumab) Poised to Disrupt the U.S. Psoriatic Arthritis Market
Nov 15, 2024
StreetInsider
Press Release: Spherix : Hope on the Horizon: Nephrologists Emphasize Need for Innovative C3G Treatments as Novartis and Apellis Prepare Therapies for FDA Submission
Nov 07, 2024
GlobalNewswire
Press Release: Spherix : Spherix Global Insights Focuses on Earlier use of Advanced Treatments in Hidradenitis Suppurativa (HS) as a Catalyst for Better Patient Outcomes
Sep 25, 2024
GlobalNewswire
Press Release: Spherix : Spherix Global Insights Expands into Financial Services, Empowering Asset Managers and Hedge Funds with Critical Pharmaceutical Market Insights
Sep 23, 2024
GlobalNewswire
Press Release: Spherix : Despite Projections of a 2024 Adalimumab Biosimilar Boom, Humira Remains Dominant for Now, According to Spherix Global Insights
Sep 12, 2024
StreetInsider
Press Release: Spherix : US Rheumatologists Believe Biogen's Litifilimab Is the Leading SLE Pipeline Asset Poised to Offer Improvement Over Benlysta and Saphnelo Based on Clinical Trial Data
Aug 29, 2024
StreetInsider
Press Release: Spherix : Ipsen's Iqirvo Shows Strong Start in Primary Biliary Cholangitis, Now Faces Rivalry from Gilead's Livdelzi
Follow and Get Alerts
Trending Companies